Published in Mol Cell Biol on November 01, 1993
A compilation of composite regulatory elements affecting gene transcription in vertebrates. Nucleic Acids Res (1995) 4.93
Displacement of an E-box-binding repressor by basic helix-loop-helix proteins: implications for B-cell specificity of the immunoglobulin heavy-chain enhancer. Mol Cell Biol (1994) 2.15
The lymphoid transcription factor LyF-1 is encoded by specific, alternatively spliced mRNAs derived from the Ikaros gene. Mol Cell Biol (1994) 1.99
ERP, a new member of the ets transcription factor/oncoprotein family: cloning, characterization, and differential expression during B-lymphocyte development. Mol Cell Biol (1994) 1.67
Multilineage priming of enhancer repertoires precedes commitment to the B and myeloid cell lineages in hematopoietic progenitors. Immunity (2011) 1.66
Spi-1/PU.1 transgenic mice develop multistep erythroleukemias. Mol Cell Biol (1996) 1.63
The human cytomegalovirus IE2 86-kilodalton protein interacts with an early gene promoter via site-specific DNA binding and protein-protein associations. J Virol (1995) 1.52
Identification of target genes for the Ewing's sarcoma EWS/FLI fusion protein by representational difference analysis. Mol Cell Biol (1995) 1.47
Isolation and characterization of a novel epithelium-specific transcription factor, ESE-1, a member of the ets family. Mol Cell Biol (1997) 1.41
An immunological renal disease in transgenic mice that overexpress Fli-1, a member of the ets family of transcription factor genes. Mol Cell Biol (1995) 1.40
Monocyte maturation controls expression of equine infectious anemia virus. J Virol (1994) 1.29
Implication of a multisubunit Ets-related transcription factor in synaptic expression of the nicotinic acetylcholine receptor. EMBO J (1998) 1.26
PU.1 and GATA: components of a mast cell-specific interleukin 4 intronic enhancer. Proc Natl Acad Sci U S A (1994) 1.24
Activation of transcription by PU.1 requires both acidic and glutamine domains. Mol Cell Biol (1996) 1.22
Net (ERP/SAP2) one of the Ras-inducible TCFs, has a novel inhibitory domain with resemblance to the helix-loop-helix motif. EMBO J (1996) 1.22
Cux/CDP homeoprotein is a component of NF-muNR and represses the immunoglobulin heavy chain intronic enhancer by antagonizing the bright transcription activator. Mol Cell Biol (1999) 1.21
EWS-erg and EWS-Fli1 fusion transcripts in Ewing's sarcoma and primitive neuroectodermal tumors with variant translocations. J Clin Invest (1994) 1.20
Transcription factor Pip can enhance DNA binding by E47, leading to transcriptional synergy involving multiple protein domains. Mol Cell Biol (1998) 1.19
Dual requirement for the ETS transcription factors Fli-1 and Erg in hematopoietic stem cells and the megakaryocyte lineage. Proc Natl Acad Sci U S A (2009) 1.18
Oncogenic activation of ERG: A predominant mechanism in prostate cancer. J Carcinog (2011) 1.13
A potential role for Elf-1 in terminal transferase gene regulation. Mol Cell Biol (1996) 1.10
The V(D)J recombinational and transcriptional activities of the immunoglobulin heavy-chain intronic enhancer can be mediated through distinct protein-binding sites in a transgenic substrate. Mol Cell Biol (1995) 1.09
IgM receptor-mediated transactivation of the IgH 3' enhancer couples a novel Elf-1-AP-1 protein complex to the developmental control of enhancer function. EMBO J (1995) 1.03
The transcription factor PU.1, necessary for B-cell development is expressed in lymphocyte predominance, but not classical Hodgkin's disease. Am J Pathol (2001) 1.01
Fine mapping of Leishmania major susceptibility Locus lmr2 and evidence of a role for Fli1 in disease and wound healing. Infect Immun (2010) 1.00
Ets family protein, erg expression in developing and adult mouse tissues by a highly specific monoclonal antibody. J Cancer (2010) 0.97
Precise alignment of sites required for mu enhancer activation in B cells. Mol Cell Biol (1996) 0.97
Pi 1 binding sites are negative regulators of bcl-2 expression in pre-B cells. Mol Cell Biol (1995) 0.96
A role for Fli-1 in B cell proliferation: implications for SLE pathogenesis. Clin Immunol (2008) 0.95
Mechanism of e47-Pip interaction on DNA resulting in transcriptional synergy and activation of immunoglobulin germ line sterile transcripts. Mol Cell Biol (2002) 0.94
The oncogene ERG: a key factor in prostate cancer. Oncogene (2015) 0.93
Combinatorial determinants of tissue-specific transcription in B cells and macrophages. Mol Cell Biol (1997) 0.92
Context dependent transactivation domains activate the immunoglobulin mu heavy chain gene enhancer. EMBO J (1996) 0.92
Basic helix-loop-helix proteins in murine type C retrovirus transcriptional regulation. J Virol (1994) 0.89
Ets-1 activates the DRA promoter in B cells. Mol Cell Biol (1994) 0.88
Identification of interacting transcription factors regulating tissue gene expression in human. BMC Genomics (2010) 0.85
The basic helix-loop-helix differentiation factor Nex1/MATH-2 functions as a key activator of the GAP-43 gene. J Neurochem (2003) 0.84
The murine AIDS defective provirus acts as an insertional mutagen in its infected target B cells. J Virol (1995) 0.82
Cloning and characterization of the 5'UTR of the rat anti-apoptotic Bcl-w gene. Biochem Biophys Res Commun (2009) 0.76
A new DNA binding and dimerization motif in immunoglobulin enhancer binding, daughterless, MyoD, and myc proteins. Cell (1989) 21.54
Interactions between heterologous helix-loop-helix proteins generate complexes that bind specifically to a common DNA sequence. Cell (1989) 14.24
B lineage--specific interactions of an immunoglobulin enhancer with cellular factors in vivo. Science (1985) 9.73
Differences and similarities in DNA-binding preferences of MyoD and E2A protein complexes revealed by binding site selection. Science (1990) 9.54
The myoD gene family: nodal point during specification of the muscle cell lineage. Science (1991) 9.53
Expression cloning of a cDNA encoding a retinoblastoma-binding protein with E2F-like properties. Cell (1992) 9.19
The macrophage and B cell-specific transcription factor PU.1 is related to the ets oncogene. Cell (1990) 8.00
The MyoD DNA binding domain contains a recognition code for muscle-specific gene activation. Cell (1990) 7.94
Protein-binding sites in Ig gene enhancers determine transcriptional activity and inducibility. Science (1987) 7.63
Multiple protein-binding sites in the 5'-flanking region regulate c-fos expression. Mol Cell Biol (1986) 7.06
Convergence of Ets- and notch-related structural motifs in a heteromeric DNA binding complex. Science (1991) 4.98
Two distinct transcription factors that bind the immunoglobulin enhancer microE5/kappa 2 motif. Science (1990) 4.93
An inhibitory domain of E12 transcription factor prevents DNA binding in E12 homodimers but not in E12 heterodimers. Cell (1991) 4.80
Cell-type-specific contacts to immunoglobulin enhancers in nuclei. Nature (1985) 3.94
Ets-related protein Elk-1 is homologous to the c-fos regulatory factor p62TCF. Nature (1992) 3.88
Interaction of murine ets-1 with GGA-binding sites establishes the ETS domain as a new DNA-binding motif. Genes Dev (1992) 3.69
Erythroleukemia induction by Friend murine leukemia virus: insertional activation of a new member of the ets gene family, Fli-1, closely linked to c-ets-1. Genes Dev (1991) 3.54
Synergistic activation of the insulin gene by a LIM-homeo domain protein and a basic helix-loop-helix protein: building a functional insulin minienhancer complex. Genes Dev (1992) 2.86
Pan: a transcriptional regulator that binds chymotrypsin, insulin, and AP-4 enhancer motifs. Genes Dev (1990) 2.46
Pancreatic beta-cell-type-specific transcription of the insulin gene is mediated by basic helix-loop-helix DNA-binding proteins. Mol Cell Biol (1991) 2.04
E2A and E2-2 are subunits of B-cell-specific E2-box DNA-binding proteins. Mol Cell Biol (1993) 2.02
The affairs of daughterless and the promiscuity of developmental regulators. Cell (1989) 1.97
Regulation of lymphoid-specific immunoglobulin mu heavy chain gene enhancer by ETS-domain proteins. Science (1993) 1.96
The erg gene: a human gene related to the ets oncogene. Proc Natl Acad Sci U S A (1987) 1.90
Identification and characterization of two functional domains within the murine heavy-chain enhancer. Mol Cell Biol (1988) 1.81
Modulation of the IgH enhancer's cell type specificity through a genetic switch. Genes Dev (1991) 1.74
Distribution and characterization of helix-loop-helix enhancer-binding proteins from pancreatic beta cells and lymphocytes. Nucleic Acids Res (1991) 1.51
Complex regulation of the immunoglobulin mu heavy-chain gene enhancer: microB, a new determinant of enhancer function. Mol Cell Biol (1990) 1.31
Involvement of a second lymphoid-specific enhancer element in the regulation of immunoglobulin heavy-chain gene expression. Mol Cell Biol (1990) 1.19
The chymotrypsin enhancer core. Specific factor binding and biological activity. J Biol Chem (1989) 1.12
Molecular analysis of dorsal-ventral polarity in Drosophila. Cell (1988) 0.95
Helix-loop-helix proteins: regulators of transcription in eucaryotic organisms. Mol Cell Biol (2000) 8.89
Functional activity of myogenic HLH proteins requires hetero-oligomerization with E12/E47-like proteins in vivo. Cell (1991) 6.48
A new homeobox gene contributes the DNA binding domain of the t(1;19) translocation protein in pre-B ALL. Cell (1990) 5.39
E2A deficiency leads to abnormalities in alphabeta T-cell development and to rapid development of T-cell lymphomas. Mol Cell Biol (1997) 3.10
Structure and function of helix-loop-helix proteins. Biochim Biophys Acta (1994) 3.06
extradenticle raises the DNA binding specificity of homeotic selector gene products. Cell (1994) 2.45
Both E12 and E47 allow commitment to the B cell lineage. Immunity (1997) 2.27
Regulation of the helix-loop-helix proteins, E2A and Id3, by the Ras-ERK MAPK cascade. Nat Immunol (2001) 2.12
Induction of early B cell factor (EBF) and multiple B lineage genes by the basic helix-loop-helix transcription factor E12. J Exp Med (1998) 2.08
Thymocyte selection is regulated by the helix-loop-helix inhibitor protein, Id3. Immunity (2000) 2.05
Early thymocyte development is regulated by modulation of E2A protein activity. J Exp Med (2001) 2.05
E2A and E2-2 are subunits of B-cell-specific E2-box DNA-binding proteins. Mol Cell Biol (1993) 2.02
E2A and EBF act in synergy with the V(D)J recombinase to generate a diverse immunoglobulin repertoire in nonlymphoid cells. Mol Cell (2000) 1.99
E2A activity is induced during B-cell activation to promote immunoglobulin class switch recombination. EMBO J (1999) 1.93
A new transcriptional-activation motif restricted to a class of helix-loop-helix proteins is functionally conserved in both yeast and mammalian cells. Mol Cell Biol (1993) 1.86
Pbx1 is converted into a transcriptional activator upon acquiring the N-terminal region of E2A in pre-B-cell acute lymphoblastoid leukemia. Proc Natl Acad Sci U S A (1993) 1.81
Neuronal death and perinatal lethality in voltage-gated sodium channel alpha(II)-deficient mice. Biophys J (2000) 1.79
The function of E- and Id proteins in lymphocyte development. Nat Rev Immunol (2001) 1.74
Human gamma-chain genes are rearranged in leukaemic T cells and map to the short arm of chromosome 7. Nature (1985) 1.66
Human T-cell gamma genes contain N segments and have marked junctional variability. Nature (1986) 1.60
Human T-cell gamma chain genes: organization, diversity, and rearrangement. Science (1986) 1.60
Id3 inhibits B lymphocyte progenitor growth and survival in response to TGF-beta. Nat Immunol (2001) 1.57
Construction, expression and recognition of an H-2 molecule lacking its carboxyl terminus. Nature (1984) 1.57
A conserved motif present in a class of helix-loop-helix proteins activates transcription by direct recruitment of the SAGA complex. Mol Cell (1999) 1.55
Ectopic expression of E47 or E12 promotes the death of E2A-deficient lymphomas. Proc Natl Acad Sci U S A (1999) 1.53
Engrailed and Hox homeodomain proteins contain a related Pbx interaction motif that recognizes a common structure present in Pbx. EMBO J (1996) 1.52
Hox gene products modulate the DNA binding activity of Pbx1 and Pbx2. Mech Dev (1995) 1.49
Oncogenic homeodomain transcription factor E2A-Pbx1 activates a novel WNT gene in pre-B acute lymphoblastoid leukemia. Proc Natl Acad Sci U S A (1999) 1.48
Dissection of serological and cytolytic T lymphocyte epitopes on murine major histocompatibility antigens by a recombinant H-2 gene separating the first two external domains. J Exp Med (1984) 1.48
Localized gene-specific induction of accessibility to V(D)J recombination induced by E2A and early B cell factor in nonlymphoid cells. J Exp Med (2001) 1.47
The hexapeptide LFPWMR in Hoxb-8 is required for cooperative DNA binding with Pbx1 and Pbx2 proteins. Proc Natl Acad Sci U S A (1995) 1.47
Thymocyte maturation is regulated by the activity of the helix-loop-helix protein, E47. J Exp Med (1999) 1.45
Cloning and sequence analysis of complementary DNA encoding an aberrantly rearranged human T-cell gamma chain. Proc Natl Acad Sci U S A (1986) 1.44
The gene for enhancer binding proteins E12/E47 lies at the t(1;19) breakpoint in acute leukemias. Science (1989) 1.41
The AD1 transactivation domain of E2A contains a highly conserved helix which is required for its activity in both Saccharomyces cerevisiae and mammalian cells. Mol Cell Biol (1996) 1.39
Positive and negative regulation of V(D)J recombination by the E2A proteins. J Exp Med (1999) 1.36
E2A proteins: essential regulators at multiple stages of B-cell development. Immunol Rev (2000) 1.32
A novel fibroblast growth factor gene expressed in the developing nervous system is a downstream target of the chimeric homeodomain oncoprotein E2A-Pbx1. Development (1997) 1.29
Localization of E2A mRNA expression in developing and adult rat tissues. Proc Natl Acad Sci U S A (1993) 1.28
The role of E2A-PBX1 in leukemogenesis. Oncogene (2001) 1.15
T cell receptor gene rearrangements define a monoclonal T cell proliferation in patients with T cell lymphocytosis and cytopenia. Blood (1986) 1.15
The role of E-proteins in B- and T-lymphocyte development. Semin Immunol (1998) 1.14
Rearrangement and expression of T-cell antigen receptor genes in human T-lymphocyte tumor lines and normal human T-cell clones: evidence for allelic exclusion of Ti beta gene expression and preferential use of a J beta 2 gene segment. Mol Cell Biol (1986) 1.14
A novel mechanism of somatic rearrangement predicted by a human T-cell antigen receptor beta-chain complementary DNA. Science (1985) 1.12
The regulation and function of the Id proteins in lymphocyte development. Oncogene (2001) 1.11
Pbx raises the DNA binding specificity but not the selectivity of antennapedia Hox proteins. Mol Cell Biol (1997) 1.10
Dpbx, a new homeobox gene closely related to the human proto-oncogene pbx1 molecular structure and developmental expression. Mech Dev (1993) 1.08
Characterization of ABF-1, a novel basic helix-loop-helix transcription factor expressed in activated B lymphocytes. Mol Cell Biol (1998) 1.07
Specific residues in the Pbx homeodomain differentially modulate the DNA-binding activity of Hox and Engrailed proteins. Development (1997) 1.03
Transcription factor regulation of B lineage commitment. Curr Opin Immunol (2001) 0.99
Activity regulation of a Hox protein and a role for the homeodomain in inhibiting transcriptional activation. EMBO J (1999) 0.98
Effect of point mutations on in vitro transcription from the promoter for the large ribosomal RNA gene of yeast mitochondria. Nucleic Acids Res (1987) 0.95
Novel genes for disease-resistance breeding. Curr Opin Plant Biol (2000) 0.94
Identification and characterization of phosphoenolpyruvate:fructose phosphotransferase systems in three Streptomyces species. Microbiology (1995) 0.93
The adenovirus DNA binding protein enhances intermolecular DNA renaturation but inhibits intramolecular DNA renaturation. Nucleic Acids Res (1993) 0.93
Induction of a diverse T cell receptor gamma/delta repertoire by the helix-loop-helix proteins E2A and HEB in nonlymphoid cells. J Exp Med (2001) 0.91
Conformational changes induced in Hoxb-8/Pbx-1 heterodimers in solution and upon interaction with specific DNA. Mol Cell Biol (1997) 0.88
Intertwining proteins in thymocyte development and cancer. Nat Immunol (2000) 0.85
c-jun inhibits insulin control element-mediated transcription by affecting the transactivation potential of the E2A gene products. Mol Cell Biol (1995) 0.85
AKR murine thymic leukemias are from a distinct thymic cell lineage and do not express the beta chain of the T-cell antigen receptor. Proc Natl Acad Sci U S A (1986) 0.84
Localization of Pbx1 transcripts in developing rat embryos. Mech Dev (1995) 0.83
Differential expression of H-2Dd and H-2Ld histocompatibility antigens. J Exp Med (1985) 0.83
E2A gene products are not required for insulin gene expression. Endocrinology (1996) 0.83
Adenovirus DNA replication: the function of the covalently bound terminal protein. Chromosoma (1992) 0.81
An Ia-positive mouse T-cell clone is functional in presenting antigen to other T cells. Immunogenetics (1985) 0.81
Transcription factors in hematopoiesis. Curr Opin Genet Dev (1999) 0.78
Recognition of the alpha-1 and alpha-2 domains of H-2 molecules by allospecific cloned T cells. J Immunol (1986) 0.77
beta 2-Microglobulin from serum associates with several class I antigens expressed on the surface of mouse L-cells. Mol Immunol (1985) 0.77
Biochemical and functional analyses of a secreted H-2Ld molecule. Mol Cell Biol (1986) 0.75
Cytotoxic T lymphocyte recognition of class I H-2 antigens after DNA-mediated gene transfer. Fed Proc (1984) 0.75
Correlation between two new methods for the isolation of human monocytes: specific reversible agglutination with a carbohydrate from pokeweed and by use of the lectin PA-4. Adv Exp Med Biol (1982) 0.75